(1 - 13 from 15
)
AstraZeneca Expands R&D in China to Boost Drug Discovery
www.bloomberg.com
[Bloomberg] - Gastric and liver cancers haven't been a major focus of Western drugmakers, creating a “huge unmet need” for treatments for those diseases in Asia, said Steve Yang, AstraZeneca's Shanghai-based head of R&D for Asia and emerging markets, who followed
Double blow to Pfizer's emerging markets strategy | Pharmafile
www.pharmafile.com
Double blow to Pfizer's emerging markets strategy. Published on at 11:51am. Dr Steve Yang will move to an expanded role at AstraZeneca in January ...
sorted by relevance / date